Association of CYP1B1 L432V polymorphism with urinary cancer susceptibility: a meta-analysis

Abstract

BackgroundThe Cytochrome P450 1B1 (CYP1B1) is a key P450 enzyme involved in the metabolism of exogenous and endogenous substrates. Previous studies have reported the existence of CYP1B1 L432V missense polymorphism in prostate, bladder and renal cancers. However, the effects of this polymorphism on the risk of these cancers remain conflicting. Therefore, we performed a meta-analysis to assess the association between L432V polymorphism and the susceptibility of urinary cancers.MethodsWe searched the PubMed database without limits on language for studies exploring the relationship of CYP1B1 L432V polymorphism and urinary cancers. Article search was supplemented by screening the references of retrieved studies manually. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated to evaluate the strength of these associations. Simultaneously, publication bias was estimated by funnel plot and Begg’s test with Stata 11 software.ResultsWe observed a significant association between CYP1B1 L432V polymorphism and urinary cancers. The overall OR (95% CI) of CC versus CG was 0.937 (0.881-0.996), the overall OR (95% CI) of CC versus CG + GG was 0.942 (0.890-0.997). Furthermore, we identified reduced risk for CC versus other phenotypes in both prostate and overall urinary cancers, when studies were limited to Caucasian or Asian patients.ConclusionsThis meta-analysis suggests that the CYP1B1 L432V polymorphism is associated with urinary cancer risk.Virtual SlidesThe virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/3108829721231527

MiR-1-3p Suppresses the Proliferation, Invasion and Migration of Bladder Cancer Cells by Up-Regulating SFRP1 Expression

“…In non-small cell lung carcinoma, the over-expression of miR-582-3p targets SFRP1 [18]. Studies have also indicated that SFRP1 is a direct target gene of both miR-27a and miR-127-3p [16,19]. In addition, Yang et al discovered that SFRP1 is likely to affect skeletal muscle development and is regulated by miR-1/206 [20].…”

Cytochrome P450 in Cancer Susceptibility and Treatment

“…Unfortunately, no association was found. However, another meta-analysis (1658 cases and 1593 controls) showed that the CYP1B1 L432V polymorphism was associated with urinary cancer risk [210].…”

Evaluation of CYP1B1, oxidative stress and phase II detoxification enzyme status in oral cancer progression model

“…Numerous studies have been conducted to ascertain the association of CYP1B1 polymorphism and susceptibility to cancers such as endometrial and urinary cancer. 26 , 27 But studies regarding its association with oral cancer susceptibility are woefully lacking. To the best of our knowledge, till date no study has been conducted which analyses the CYP1B1 polymorphism and its association with the oxidant -antioxidant status in oral premalignancy and malignancy.…”